Stability decisions in pharmaceutical development require extensive data, often scattered across incompatible systems. For scientists, this complicates analysis, increases errors, and hinders collaboration.
Luminata® streamlines forced degradation and accelerated predictive stability (APS) studies by consolidating data into a chemically intelligent platform, enabling efficient analysis and informed decision-making.
Join this webinar to see how Luminata accelerates and simplifies stability workflows by allowing scientists to:
- Assemble and visualize analytical, chemical, and in silico data
- Organize and visualize degradant pathways into Forced Degradation project maps
- Model degradation trends and assess stability under different conditions